Pharmaxis Analysis
Pharmaxis is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Pharmaxis pink sheet analysis is to determine its intrinsic value, which is an estimate of what Pharmaxis is worth, separate from its market price. There are two main types of Pharmaxis' stock analysis: fundamental analysis and technical analysis.
The Pharmaxis pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pharmaxis' ongoing operational relationships across important fundamental and technical indicators.
Pharmaxis |
Pharmaxis Pink Sheet Analysis Notes
About 17.0% of the company outstanding shares are owned by corporate insiders. The book value of Pharmaxis was at this time reported as 0.02. The company recorded a loss per share of 0.02. Pharmaxis had not issued any dividends in recent years. Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia. Pharmaxis operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 65 people.The quote for Pharmaxis is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharmaxis contact MBA BPharm at 61 2 9454 7200 or learn more at https://www.pharmaxis.com.au.Pharmaxis Investment Alerts
| Pharmaxis is not yet fully synchronised with the market data | |
| Pharmaxis has some characteristics of a very speculative penny stock | |
| Pharmaxis has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 7.43 M. Net Loss for the year was (1.94 M) with profit before overhead, payroll, taxes, and interest of 5.8 M. | |
| Pharmaxis has accumulated about 8.94 M in cash with (16.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Pharmaxis Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pharmaxis's market, we take the total number of its shares issued and multiply it by Pharmaxis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Pharmaxis Profitablity
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.76.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Pharmaxis to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Pharmaxis Pink Sheet
If you are still planning to invest in Pharmaxis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmaxis' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |